加拿大医院碳青霉烯耐药铜绿假单胞菌特征:CANWARD研究6年结果(2018-23)
CANWARD国家监测项目2018至2023年收集1725株铜绿假单胞菌,其中371株(21.5%)对碳青霉烯耐药。仅0.8%(3株)携带碳青霉烯酶基因,耐药主要由OprD功能缺陷(73.6%)等机制介导,并观察到高风险克隆的克隆传播。
要点
- 加拿大临床铜绿假单胞菌中碳青霉烯耐药率超20%。
- 碳青霉烯酶基因罕见(0.8%),耐药多由OprD缺陷等非酶机制所致。
- 高风险克隆(如ST235、ST244等)存在克隆传播,需持续监测。
核心结论
- 加拿大临床分离的铜绿假单胞菌中超过20%对碳青霉烯耐药,且高风险克隆的克隆传播正在发生。
研究设计与样本
- CANWARD国家监测项目2018至2023年收集1725株铜绿假单胞菌,采用肉汤微量稀释法和2024 CLSI折点进行药敏试验,对碳青霉烯耐药株行全基因组测序及cgMLST分析。
主要发现
- 371株(21.5%)为碳青霉烯耐药,主要分离自加拿大中部18-65岁男性患者的呼吸道标本。
- 仅0.8%(n=3)的碳青霉烯耐药株携带碳青霉烯酶基因。
- 全基因组测序显示OprD功能缺陷相关突变占73.6%,MexAB-OprM外排上调占1.1%,AmpC过表达占4.9%。
- 98.1%的菌株携带至少一种D类β-内酰胺酶基因(OXA-2、OXA-5、OXA-10或OXA-50样亚家族)。
- 共鉴定151种ST型,常见ST包括ST17(4.6%)、ST27(4.6%)、ST253(6.4%),高风险克隆ST235(4.3%)、ST244(3.5%)、ST357(2.7%);34.9%的高风险克隆形成cgMLST簇。
临床怎么用
- 在加拿大经验性治疗碳青霉烯耐药铜绿假单胞菌感染时,应考虑到碳青霉烯酶基因罕见而非酶机制为主。
- 对高风险克隆的克隆传播需加强院感防控和持续分子监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Antimicrobial resistance in Pseudomonas aeruginosa is of increasing concern in Canada, leading to limited treatment options and poor clinical outcomes. Herein we characterized carbapenem-resistant P. aeruginosa identified through the Canadian national surveillance program CANWARD. METHODS: Antimicrobial susceptibility for 1725 P. aeruginosa isolates was assessed using broth microdilution and 2024 CLSI breakpoints. WGS of carbapenem-resistant isolates was used to identify STs, resistance and virulence markers. Genetic relatedness was further assessed using cgMLST for select STs. RESULTS: From 2018 to 2023, CANWARD collected 1725 P. aeruginosa isolates, of which 371 (21.5%) were carbapenem-resistant. The majority of carbapenem-resistant P. aeruginosa were isolated from respiratory specimens of male patients aged 18-65 years living in central Canada. Only 0.8% (n = 3) of the carbapenem-resistant isolates harboured a carbapenemase gene. WGS identified mutations associated with OprD dysfunction, MexAB-OprM efflux and AmpC overexpression in 73.6%, 1.1% and 4.9% of isolates, respectively. Most isolates (98.1%) harboured at least one of the following class D β-lactamase genes: OXA-2, OXA-5, OXA-10 or OXA-50-like subfamily. Wide genetic diversity was observed with 151 different STs identified. The most common STs were ST17 (4.6%), ST27 (4.6%) and high-risk clones ST235 (4.3%), ST244 (3.5%), ST253 (6.4%) and ST357 (2.7%). cgMLST clusters were identified amongst 34.9% of the high-risk clones, suggesting clonal dissemination. CONCLUSIONS: Currently, >20% of clinical isolates of P. aeruginosa in Canada are carbapenem-resistant. Genetic evidence indicates that clonal dissemination of high-risk clones is occurring in Canada. High-risk clones are virulent and often MDR. Continued surveillance of P. aeruginosa is important.
引用
- McCracken M, Walkty A, Adam HJ, et al. Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23). J Antimicrob Chemother. 2025. PMID: 40873031. doi:10.1093/jac/dkaf222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。